Precision · Health · Capital

Building, scaling, and exiting digitally enabled companies.

I'm Charles Cornish, a hands on CEO who leads early-stage and turnaround businesses out of trouble and into the hands of the natural owners, or follow-on investments.

Portrait of Charles Cornish
Charles Cornish
Operator & turnaround CEO
2
CEO-led exits
20+
Years operating
3
Markets · US AU BRMarkets US AU BR
Track record

Two exits. One playbook.

Both companies had underutilized assets that required strong leadership, clear strategy, people-first execution in order to attract and execute on exits to strategic buyers.

Exit · Acquired

Monarch Medical Technologies

CEO & co-owner · EndoTool Glucose Management

Led the company through to a strategic divestment to a clinically aligned acquirer.

→ Acquired by Glooko · 2025
Precision insulin dosing · inpatient glycemic management
Exit · Acquired

DoseMe / DoseMeRx

CEO & co-owner · Bayesian precision dosing

Relaunched the business and led it to acquisition by a NASDAQ-listed medication-safety company.

→ Acquired by Tabula Rasa HealthCare (NASDAQ: TRHC) · 2019
Real-time precision dosing for clinical care
Career

Twenty years to the CEO seat.

From corporate finance to operating leadership across the US, Australia, and Brazil, with product reach into Europe.

2023 – 2025
Chief Executive Officer
United States
2019 – 2022
Tabula Rasa HealthCare
Chief Partnership Officer · NASDAQ: TRHC
United States
2015 – 2019
DoseMe / DoseMeRx
Chief Executive Officer
Australia → US
2010 – 2015
Ontex Australia
Managing Director
Australia
2007 – 2009
Dalton Nicol Reid
Chief Operating Officer
Australia
2003 – 2008
Eli Lilly and Company
Strategy & Commercial
Australia
1999 – 2002
KPMG
Corporate Finance, Senior Manager
Brazil
Approach

I take software companies that have stalled (distressed, underperforming, or early-stage) and get them into the optimal window, then to a clean exit.

Actively evaluatingCEO mandates and acquisition targets small to medium businesses often turnarounds or struggling early-stage companies in need of leadership, capital, or both.

Operator

PE portfolio CEO & turnaround

I step into the CEO seat and run the company to a strategic exit. It's the role I've played twice.

Advisor

Strategic advisory

Commercialization, go-to-market, and deal structure for precision-medicine companies.

Capital

Assembled with PE partners

I can help bring capital to the table, drawing on follow-on investors from prior exits.

Credentials

Finance discipline, clinical fluency.

Melbourne Business School
Master of Business AdministrationMelbourne Business School
Chartered Accountants Australia & New Zealand
Chartered AccountantChartered Accountants Australia & New Zealand
Massachusetts Institute of Technology
Executive Program, Healthcare AIMassachusetts Institute of Technology
Australian Institute of Company Directors
Graduate, Company Directors (GAICD)Australian Institute of Company Directors
Queensland University of Technology
Bachelor of Business, Banking & FinanceQueensland University of Technology
MBA CPA MIT AI in Healthcare Digital Health SaaS · AI-Enabled Solutions M&A · Exit Experience US · Australia · EU/UK · Brazil
Open to conversations

Let's talk.

PE firms, struggling founders, frustrated investors, executive search, and strategic partners: if there's a fit, I'd like to hear from you.